10-Q 1 gild-20220630.htm FORM 10-Q gild-20220630
000088209512/312022Q2false00008820952022-01-012022-06-3000008820952022-07-29xbrli:shares00008820952022-06-30iso4217:USD00008820952021-12-31iso4217:USDxbrli:shares0000882095us-gaap:ProductMember2022-04-012022-06-300000882095us-gaap:ProductMember2021-04-012021-06-300000882095us-gaap:ProductMember2022-01-012022-06-300000882095us-gaap:ProductMember2021-01-012021-06-300000882095gild:RoyaltyContractAndOtherMember2022-04-012022-06-300000882095gild:RoyaltyContractAndOtherMember2021-04-012021-06-300000882095gild:RoyaltyContractAndOtherMember2022-01-012022-06-300000882095gild:RoyaltyContractAndOtherMember2021-01-012021-06-3000008820952022-04-012022-06-3000008820952021-04-012021-06-3000008820952021-01-012021-06-300000882095us-gaap:CommonStockMember2022-03-310000882095us-gaap:AdditionalPaidInCapitalMember2022-03-310000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000882095us-gaap:RetainedEarningsMember2022-03-310000882095us-gaap:NoncontrollingInterestMember2022-03-3100008820952022-03-310000882095us-gaap:RetainedEarningsMember2022-04-012022-06-300000882095us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000882095us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000882095us-gaap:CommonStockMember2022-04-012022-06-300000882095us-gaap:CommonStockMember2022-06-300000882095us-gaap:AdditionalPaidInCapitalMember2022-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000882095us-gaap:RetainedEarningsMember2022-06-300000882095us-gaap:NoncontrollingInterestMember2022-06-300000882095us-gaap:CommonStockMember2021-12-310000882095us-gaap:AdditionalPaidInCapitalMember2021-12-310000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000882095us-gaap:RetainedEarningsMember2021-12-310000882095us-gaap:NoncontrollingInterestMember2021-12-310000882095us-gaap:RetainedEarningsMember2022-01-012022-06-300000882095us-gaap:NoncontrollingInterestMember2022-01-012022-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300000882095us-gaap:CommonStockMember2022-01-012022-06-300000882095us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300000882095us-gaap:CommonStockMember2021-03-310000882095us-gaap:AdditionalPaidInCapitalMember2021-03-310000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000882095us-gaap:RetainedEarningsMember2021-03-310000882095us-gaap:NoncontrollingInterestMember2021-03-3100008820952021-03-310000882095us-gaap:RetainedEarningsMember2021-04-012021-06-300000882095us-gaap:NoncontrollingInterestMember2021-04-012021-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000882095us-gaap:CommonStockMember2021-04-012021-06-300000882095us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300000882095us-gaap:CommonStockMember2021-06-300000882095us-gaap:AdditionalPaidInCapitalMember2021-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000882095us-gaap:RetainedEarningsMember2021-06-300000882095us-gaap:NoncontrollingInterestMember2021-06-3000008820952021-06-300000882095us-gaap:CommonStockMember2020-12-310000882095us-gaap:AdditionalPaidInCapitalMember2020-12-310000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000882095us-gaap:RetainedEarningsMember2020-12-310000882095us-gaap:NoncontrollingInterestMember2020-12-3100008820952020-12-310000882095us-gaap:RetainedEarningsMember2021-01-012021-06-300000882095us-gaap:NoncontrollingInterestMember2021-01-012021-06-300000882095us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300000882095us-gaap:CommonStockMember2021-01-012021-06-300000882095us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300000882095srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-04-012021-06-300000882095srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2021-01-012021-06-300000882095srt:RevisionOfPriorPeriodReclassificationAdjustmentMember2022-01-012022-03-310000882095country:USgild:HIVProductsBiktarvyMember2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsBiktarvyMember2022-04-012022-06-300000882095gild:HIVProductsBiktarvyMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HIVProductsBiktarvyMember2022-04-012022-06-300000882095country:USgild:HIVProductsBiktarvyMember2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsBiktarvyMember2021-04-012021-06-300000882095gild:HIVProductsBiktarvyMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HIVProductsBiktarvyMember2021-04-012021-06-300000882095country:USgild:HIVProductsCompleraEvipleraMember2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsCompleraEvipleraMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsCompleraEvipleraMember2022-04-012022-06-300000882095gild:HIVProductsCompleraEvipleraMember2022-04-012022-06-300000882095country:USgild:HIVProductsCompleraEvipleraMember2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsCompleraEvipleraMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsCompleraEvipleraMember2021-04-012021-06-300000882095gild:HIVProductsCompleraEvipleraMember2021-04-012021-06-300000882095country:USgild:HIVProductsDescovyMember2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsDescovyMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsDescovyMember2022-04-012022-06-300000882095gild:HIVProductsDescovyMember2022-04-012022-06-300000882095country:USgild:HIVProductsDescovyMember2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsDescovyMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsDescovyMember2021-04-012021-06-300000882095gild:HIVProductsDescovyMember2021-04-012021-06-300000882095gild:HIVProductsGenvoyaMembercountry:US2022-04-012022-06-300000882095gild:HIVProductsGenvoyaMembersrt:EuropeMember2022-04-012022-06-300000882095gild:HIVProductsGenvoyaMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HIVProductsGenvoyaMember2022-04-012022-06-300000882095gild:HIVProductsGenvoyaMembercountry:US2021-04-012021-06-300000882095gild:HIVProductsGenvoyaMembersrt:EuropeMember2021-04-012021-06-300000882095gild:HIVProductsGenvoyaMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HIVProductsGenvoyaMember2021-04-012021-06-300000882095country:USgild:HIVProductsOdefseyMember2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsOdefseyMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsOdefseyMember2022-04-012022-06-300000882095gild:HIVProductsOdefseyMember2022-04-012022-06-300000882095country:USgild:HIVProductsOdefseyMember2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsOdefseyMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsOdefseyMember2021-04-012021-06-300000882095gild:HIVProductsOdefseyMember2021-04-012021-06-300000882095gild:HIVProductsStribildMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsStribildMember2022-04-012022-06-300000882095gild:HIVProductsStribildMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HIVProductsStribildMember2022-04-012022-06-300000882095gild:HIVProductsStribildMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsStribildMember2021-04-012021-06-300000882095gild:HIVProductsStribildMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HIVProductsStribildMember2021-04-012021-06-300000882095gild:HIVProductsTruvadaMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductsTruvadaMember2022-04-012022-06-300000882095gild:HIVProductsTruvadaMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HIVProductsTruvadaMember2022-04-012022-06-300000882095gild:HIVProductsTruvadaMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductsTruvadaMember2021-04-012021-06-300000882095gild:HIVProductsTruvadaMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HIVProductsTruvadaMember2021-04-012021-06-300000882095country:USgild:ProductsRevenueShareSymtuzaMember2022-04-012022-06-300000882095srt:EuropeMembergild:ProductsRevenueShareSymtuzaMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:ProductsRevenueShareSymtuzaMember2022-04-012022-06-300000882095gild:ProductsRevenueShareSymtuzaMember2022-04-012022-06-300000882095country:USgild:ProductsRevenueShareSymtuzaMember2021-04-012021-06-300000882095srt:EuropeMembergild:ProductsRevenueShareSymtuzaMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:ProductsRevenueShareSymtuzaMember2021-04-012021-06-300000882095gild:ProductsRevenueShareSymtuzaMember2021-04-012021-06-300000882095country:USgild:ProductsOtherHIVMember2022-04-012022-06-300000882095srt:EuropeMembergild:ProductsOtherHIVMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:ProductsOtherHIVMember2022-04-012022-06-300000882095gild:ProductsOtherHIVMember2022-04-012022-06-300000882095country:USgild:ProductsOtherHIVMember2021-04-012021-06-300000882095srt:EuropeMembergild:ProductsOtherHIVMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:ProductsOtherHIVMember2021-04-012021-06-300000882095gild:ProductsOtherHIVMember2021-04-012021-06-300000882095gild:HIVProductSalesMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:HIVProductSalesMember2022-04-012022-06-300000882095gild:HIVProductSalesMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HIVProductSalesMember2022-04-012022-06-300000882095gild:HIVProductSalesMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:HIVProductSalesMember2021-04-012021-06-300000882095gild:HIVProductSalesMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HIVProductSalesMember2021-04-012021-06-300000882095country:USgild:VekluryMember2022-04-012022-06-300000882095srt:EuropeMembergild:VekluryMember2022-04-012022-06-300000882095gild:VekluryMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:VekluryMember2022-04-012022-06-300000882095country:USgild:VekluryMember2021-04-012021-06-300000882095srt:EuropeMembergild:VekluryMember2021-04-012021-06-300000882095gild:VekluryMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:VekluryMember2021-04-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:HCVProductsLedipasvirSofosbuvirMember2022-04-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMember2022-04-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:HCVProductsLedipasvirSofosbuvirMember2021-04-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMember2021-04-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembercountry:US2022-04-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembersrt:EuropeMember2022-04-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMember2022-04-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembercountry:US2021-04-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembersrt:EuropeMember2021-04-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMember2021-04-012021-06-300000882095country:USgild:OtherHepatitisCVirusProductsMember2022-04-012022-06-300000882095srt:EuropeMembergild:OtherHepatitisCVirusProductsMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:OtherHepatitisCVirusProductsMember2022-04-012022-06-300000882095gild:OtherHepatitisCVirusProductsMember2022-04-012022-06-300000882095country:USgild:OtherHepatitisCVirusProductsMember2021-04-012021-06-300000882095srt:EuropeMembergild:OtherHepatitisCVirusProductsMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:OtherHepatitisCVirusProductsMember2021-04-012021-06-300000882095gild:OtherHepatitisCVirusProductsMember2021-04-012021-06-300000882095gild:HCVProductSalesMembercountry:US2022-04-012022-06-300000882095gild:HCVProductSalesMembersrt:EuropeMember2022-04-012022-06-300000882095gild:HCVProductSalesMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HCVProductSalesMember2022-04-012022-06-300000882095gild:HCVProductSalesMembercountry:US2021-04-012021-06-300000882095gild:HCVProductSalesMembersrt:EuropeMember2021-04-012021-06-300000882095gild:HCVProductSalesMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HCVProductSalesMember2021-04-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-04-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-04-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-04-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-04-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-04-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-04-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-04-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-04-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-04-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-04-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-04-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMember2022-04-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMember2021-04-012021-06-300000882095gild:CellTherapyProductsTecartusMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:CellTherapyProductsTecartusMember2022-04-012022-06-300000882095gild:CellTherapyProductsTecartusMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:CellTherapyProductsTecartusMember2022-04-012022-06-300000882095gild:CellTherapyProductsTecartusMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:CellTherapyProductsTecartusMember2021-04-012021-06-300000882095gild:CellTherapyProductsTecartusMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:CellTherapyProductsTecartusMember2021-04-012021-06-300000882095country:USgild:CellTherapyProductsYescartaMember2022-04-012022-06-300000882095srt:EuropeMembergild:CellTherapyProductsYescartaMember2022-04-012022-06-300000882095gild:OtherInternationalMembergild:CellTherapyProductsYescartaMember2022-04-012022-06-300000882095gild:CellTherapyProductsYescartaMember2022-04-012022-06-300000882095country:USgild:CellTherapyProductsYescartaMember2021-04-012021-06-300000882095srt:EuropeMembergild:CellTherapyProductsYescartaMember2021-04-012021-06-300000882095gild:OtherInternationalMembergild:CellTherapyProductsYescartaMember2021-04-012021-06-300000882095gild:CellTherapyProductsYescartaMember2021-04-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembercountry:US2022-04-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembersrt:EuropeMember2022-04-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMember2022-04-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembercountry:US2021-04-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembersrt:EuropeMember2021-04-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMember2021-04-012021-06-300000882095country:USgild:TrodelvyMember2022-04-012022-06-300000882095srt:EuropeMembergild:TrodelvyMember2022-04-012022-06-300000882095gild:TrodelvyMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:TrodelvyMember2022-04-012022-06-300000882095country:USgild:TrodelvyMember2021-04-012021-06-300000882095srt:EuropeMembergild:TrodelvyMember2021-04-012021-06-300000882095gild:TrodelvyMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:TrodelvyMember2021-04-012021-06-300000882095country:USgild:OtherProductsAmBisomeMember2022-04-012022-06-300000882095srt:EuropeMembergild:OtherProductsAmBisomeMember2022-04-012022-06-300000882095gild:OtherProductsAmBisomeMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:OtherProductsAmBisomeMember2022-04-012022-06-300000882095country:USgild:OtherProductsAmBisomeMember2021-04-012021-06-300000882095srt:EuropeMembergild:OtherProductsAmBisomeMember2021-04-012021-06-300000882095gild:OtherProductsAmBisomeMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:OtherProductsAmBisomeMember2021-04-012021-06-300000882095gild:OtherProductsLetairisMembercountry:US2022-04-012022-06-300000882095srt:EuropeMembergild:OtherProductsLetairisMember2022-04-012022-06-300000882095gild:OtherProductsLetairisMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:OtherProductsLetairisMember2022-04-012022-06-300000882095gild:OtherProductsLetairisMembercountry:US2021-04-012021-06-300000882095srt:EuropeMembergild:OtherProductsLetairisMember2021-04-012021-06-300000882095gild:OtherProductsLetairisMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:OtherProductsLetairisMember2021-04-012021-06-300000882095gild:OtherProductsOtherMembercountry:US2022-04-012022-06-300000882095gild:OtherProductsOtherMembersrt:EuropeMember2022-04-012022-06-300000882095gild:OtherProductsOtherMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:OtherProductsOtherMember2022-04-012022-06-300000882095gild:OtherProductsOtherMembercountry:US2021-04-012021-06-300000882095gild:OtherProductsOtherMembersrt:EuropeMember2021-04-012021-06-300000882095gild:OtherProductsOtherMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:OtherProductsOtherMember2021-04-012021-06-300000882095country:USgild:OtherProductsTotalOtherProductSalesMember2022-04-012022-06-300000882095srt:EuropeMembergild:OtherProductsTotalOtherProductSalesMember2022-04-012022-06-300000882095gild:OtherProductsTotalOtherProductSalesMembergild:OtherInternationalMember2022-04-012022-06-300000882095gild:OtherProductsTotalOtherProductSalesMember2022-04-012022-06-300000882095country:USgild:OtherProductsTotalOtherProductSalesMember2021-04-012021-06-300000882095srt:EuropeMembergild:OtherProductsTotalOtherProductSalesMember2021-04-012021-06-300000882095gild:OtherProductsTotalOtherProductSalesMembergild:OtherInternationalMember2021-04-012021-06-300000882095gild:OtherProductsTotalOtherProductSalesMember2021-04-012021-06-300000882095us-gaap:ProductMembercountry:US2022-04-012022-06-300000882095srt:EuropeMemberus-gaap:ProductMember2022-04-012022-06-300000882095us-gaap:ProductMembergild:OtherInternationalMember2022-04-012022-06-300000882095us-gaap:ProductMembercountry:US2021-04-012021-06-300000882095srt:EuropeMemberus-gaap:ProductMember2021-04-012021-06-300000882095us-gaap:ProductMembergild:OtherInternationalMember2021-04-012021-06-300000882095country:USgild:RoyaltyContractAndOtherMember2022-04-012022-06-300000882095srt:EuropeMembergild:RoyaltyContractAndOtherMember2022-04-012022-06-300000882095gild:RoyaltyContractAndOtherMembergild:OtherInternationalMember2022-04-012022-06-300000882095country:USgild:RoyaltyContractAndOtherMember2021-04-012021-06-300000882095srt:EuropeMembergild:RoyaltyContractAndOtherMember2021-04-012021-06-300000882095gild:RoyaltyContractAndOtherMembergild:OtherInternationalMember2021-04-012021-06-300000882095country:US2022-04-012022-06-300000882095srt:EuropeMember2022-04-012022-06-300000882095gild:OtherInternationalMember2022-04-012022-06-300000882095country:US2021-04-012021-06-300000882095srt:EuropeMember2021-04-012021-06-300000882095gild:OtherInternationalMember2021-04-012021-06-300000882095country:USgild:HIVProductsBiktarvyMember2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsBiktarvyMember2022-01-012022-06-300000882095gild:HIVProductsBiktarvyMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HIVProductsBiktarvyMember2022-01-012022-06-300000882095country:USgild:HIVProductsBiktarvyMember2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsBiktarvyMember2021-01-012021-06-300000882095gild:HIVProductsBiktarvyMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HIVProductsBiktarvyMember2021-01-012021-06-300000882095country:USgild:HIVProductsCompleraEvipleraMember2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsCompleraEvipleraMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsCompleraEvipleraMember2022-01-012022-06-300000882095gild:HIVProductsCompleraEvipleraMember2022-01-012022-06-300000882095country:USgild:HIVProductsCompleraEvipleraMember2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsCompleraEvipleraMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsCompleraEvipleraMember2021-01-012021-06-300000882095gild:HIVProductsCompleraEvipleraMember2021-01-012021-06-300000882095country:USgild:HIVProductsDescovyMember2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsDescovyMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsDescovyMember2022-01-012022-06-300000882095gild:HIVProductsDescovyMember2022-01-012022-06-300000882095country:USgild:HIVProductsDescovyMember2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsDescovyMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsDescovyMember2021-01-012021-06-300000882095gild:HIVProductsDescovyMember2021-01-012021-06-300000882095gild:HIVProductsGenvoyaMembercountry:US2022-01-012022-06-300000882095gild:HIVProductsGenvoyaMembersrt:EuropeMember2022-01-012022-06-300000882095gild:HIVProductsGenvoyaMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HIVProductsGenvoyaMember2022-01-012022-06-300000882095gild:HIVProductsGenvoyaMembercountry:US2021-01-012021-06-300000882095gild:HIVProductsGenvoyaMembersrt:EuropeMember2021-01-012021-06-300000882095gild:HIVProductsGenvoyaMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HIVProductsGenvoyaMember2021-01-012021-06-300000882095country:USgild:HIVProductsOdefseyMember2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsOdefseyMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:HIVProductsOdefseyMember2022-01-012022-06-300000882095gild:HIVProductsOdefseyMember2022-01-012022-06-300000882095country:USgild:HIVProductsOdefseyMember2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsOdefseyMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:HIVProductsOdefseyMember2021-01-012021-06-300000882095gild:HIVProductsOdefseyMember2021-01-012021-06-300000882095gild:HIVProductsStribildMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsStribildMember2022-01-012022-06-300000882095gild:HIVProductsStribildMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HIVProductsStribildMember2022-01-012022-06-300000882095gild:HIVProductsStribildMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsStribildMember2021-01-012021-06-300000882095gild:HIVProductsStribildMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HIVProductsStribildMember2021-01-012021-06-300000882095gild:HIVProductsTruvadaMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductsTruvadaMember2022-01-012022-06-300000882095gild:HIVProductsTruvadaMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HIVProductsTruvadaMember2022-01-012022-06-300000882095gild:HIVProductsTruvadaMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductsTruvadaMember2021-01-012021-06-300000882095gild:HIVProductsTruvadaMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HIVProductsTruvadaMember2021-01-012021-06-300000882095country:USgild:ProductsRevenueShareSymtuzaMember2022-01-012022-06-300000882095srt:EuropeMembergild:ProductsRevenueShareSymtuzaMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:ProductsRevenueShareSymtuzaMember2022-01-012022-06-300000882095gild:ProductsRevenueShareSymtuzaMember2022-01-012022-06-300000882095country:USgild:ProductsRevenueShareSymtuzaMember2021-01-012021-06-300000882095srt:EuropeMembergild:ProductsRevenueShareSymtuzaMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:ProductsRevenueShareSymtuzaMember2021-01-012021-06-300000882095gild:ProductsRevenueShareSymtuzaMember2021-01-012021-06-300000882095country:USgild:ProductsOtherHIVMember2022-01-012022-06-300000882095srt:EuropeMembergild:ProductsOtherHIVMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:ProductsOtherHIVMember2022-01-012022-06-300000882095gild:ProductsOtherHIVMember2022-01-012022-06-300000882095country:USgild:ProductsOtherHIVMember2021-01-012021-06-300000882095srt:EuropeMembergild:ProductsOtherHIVMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:ProductsOtherHIVMember2021-01-012021-06-300000882095gild:ProductsOtherHIVMember2021-01-012021-06-300000882095gild:HIVProductSalesMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:HIVProductSalesMember2022-01-012022-06-300000882095gild:HIVProductSalesMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HIVProductSalesMember2022-01-012022-06-300000882095gild:HIVProductSalesMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:HIVProductSalesMember2021-01-012021-06-300000882095gild:HIVProductSalesMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HIVProductSalesMember2021-01-012021-06-300000882095country:USgild:VekluryMember2022-01-012022-06-300000882095srt:EuropeMembergild:VekluryMember2022-01-012022-06-300000882095gild:VekluryMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:VekluryMember2022-01-012022-06-300000882095country:USgild:VekluryMember2021-01-012021-06-300000882095srt:EuropeMembergild:VekluryMember2021-01-012021-06-300000882095gild:VekluryMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:VekluryMember2021-01-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:HCVProductsLedipasvirSofosbuvirMember2022-01-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMember2022-01-012022-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:HCVProductsLedipasvirSofosbuvirMember2021-01-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HCVProductsLedipasvirSofosbuvirMember2021-01-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembercountry:US2022-01-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembersrt:EuropeMember2022-01-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMember2022-01-012022-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembercountry:US2021-01-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembersrt:EuropeMember2021-01-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HCVProductsSofosbuvirVelpatasvirMember2021-01-012021-06-300000882095country:USgild:OtherHepatitisCVirusProductsMember2022-01-012022-06-300000882095srt:EuropeMembergild:OtherHepatitisCVirusProductsMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:OtherHepatitisCVirusProductsMember2022-01-012022-06-300000882095gild:OtherHepatitisCVirusProductsMember2022-01-012022-06-300000882095country:USgild:OtherHepatitisCVirusProductsMember2021-01-012021-06-300000882095srt:EuropeMembergild:OtherHepatitisCVirusProductsMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:OtherHepatitisCVirusProductsMember2021-01-012021-06-300000882095gild:OtherHepatitisCVirusProductsMember2021-01-012021-06-300000882095gild:HCVProductSalesMembercountry:US2022-01-012022-06-300000882095gild:HCVProductSalesMembersrt:EuropeMember2022-01-012022-06-300000882095gild:HCVProductSalesMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HCVProductSalesMember2022-01-012022-06-300000882095gild:HCVProductSalesMembercountry:US2021-01-012021-06-300000882095gild:HCVProductSalesMembersrt:EuropeMember2021-01-012021-06-300000882095gild:HCVProductSalesMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HCVProductSalesMember2021-01-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-01-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2022-01-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-01-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVemlidyMember2021-01-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-01-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2022-01-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-01-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductVireadMember2021-01-012021-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-01-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2022-01-012022-06-300000882095country:USgild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-01-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductOtherMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMember2022-01-012022-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:HepatitisBVirusHepatitisDeltaVirusProductMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:HepatitisBVirusHepatitisDeltaVirusProductMember2021-01-012021-06-300000882095gild:CellTherapyProductsTecartusMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:CellTherapyProductsTecartusMember2022-01-012022-06-300000882095gild:CellTherapyProductsTecartusMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:CellTherapyProductsTecartusMember2022-01-012022-06-300000882095gild:CellTherapyProductsTecartusMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:CellTherapyProductsTecartusMember2021-01-012021-06-300000882095gild:CellTherapyProductsTecartusMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:CellTherapyProductsTecartusMember2021-01-012021-06-300000882095country:USgild:CellTherapyProductsYescartaMember2022-01-012022-06-300000882095srt:EuropeMembergild:CellTherapyProductsYescartaMember2022-01-012022-06-300000882095gild:OtherInternationalMembergild:CellTherapyProductsYescartaMember2022-01-012022-06-300000882095gild:CellTherapyProductsYescartaMember2022-01-012022-06-300000882095country:USgild:CellTherapyProductsYescartaMember2021-01-012021-06-300000882095srt:EuropeMembergild:CellTherapyProductsYescartaMember2021-01-012021-06-300000882095gild:OtherInternationalMembergild:CellTherapyProductsYescartaMember2021-01-012021-06-300000882095gild:CellTherapyProductsYescartaMember2021-01-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembercountry:US2022-01-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembersrt:EuropeMember2022-01-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMember2022-01-012022-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembercountry:US2021-01-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembersrt:EuropeMember2021-01-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:CellTherapyProductsTotalCellTherapyProductSalesMember2021-01-012021-06-300000882095country:USgild:TrodelvyMember2022-01-012022-06-300000882095srt:EuropeMembergild:TrodelvyMember2022-01-012022-06-300000882095gild:TrodelvyMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:TrodelvyMember2022-01-012022-06-300000882095country:USgild:TrodelvyMember2021-01-012021-06-300000882095srt:EuropeMembergild:TrodelvyMember2021-01-012021-06-300000882095gild:TrodelvyMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:TrodelvyMember2021-01-012021-06-300000882095country:USgild:OtherProductsAmBisomeMember2022-01-012022-06-300000882095srt:EuropeMembergild:OtherProductsAmBisomeMember2022-01-012022-06-300000882095gild:OtherProductsAmBisomeMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:OtherProductsAmBisomeMember2022-01-012022-06-300000882095country:USgild:OtherProductsAmBisomeMember2021-01-012021-06-300000882095srt:EuropeMembergild:OtherProductsAmBisomeMember2021-01-012021-06-300000882095gild:OtherProductsAmBisomeMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:OtherProductsAmBisomeMember2021-01-012021-06-300000882095gild:OtherProductsLetairisMembercountry:US2022-01-012022-06-300000882095srt:EuropeMembergild:OtherProductsLetairisMember2022-01-012022-06-300000882095gild:OtherProductsLetairisMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:OtherProductsLetairisMember2022-01-012022-06-300000882095gild:OtherProductsLetairisMembercountry:US2021-01-012021-06-300000882095srt:EuropeMembergild:OtherProductsLetairisMember2021-01-012021-06-300000882095gild:OtherProductsLetairisMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:OtherProductsLetairisMember2021-01-012021-06-300000882095gild:OtherProductsOtherMembercountry:US2022-01-012022-06-300000882095gild:OtherProductsOtherMembersrt:EuropeMember2022-01-012022-06-300000882095gild:OtherProductsOtherMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:OtherProductsOtherMember2022-01-012022-06-300000882095gild:OtherProductsOtherMembercountry:US2021-01-012021-06-300000882095gild:OtherProductsOtherMembersrt:EuropeMember2021-01-012021-06-300000882095gild:OtherProductsOtherMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:OtherProductsOtherMember2021-01-012021-06-300000882095country:USgild:OtherProductsTotalOtherProductSalesMember2022-01-012022-06-300000882095srt:EuropeMembergild:OtherProductsTotalOtherProductSalesMember2022-01-012022-06-300000882095gild:OtherProductsTotalOtherProductSalesMembergild:OtherInternationalMember2022-01-012022-06-300000882095gild:OtherProductsTotalOtherProductSalesMember2022-01-012022-06-300000882095country:USgild:OtherProductsTotalOtherProductSalesMember2021-01-012021-06-300000882095srt:EuropeMembergild:OtherProductsTotalOtherProductSalesMember2021-01-012021-06-300000882095gild:OtherProductsTotalOtherProductSalesMembergild:OtherInternationalMember2021-01-012021-06-300000882095gild:OtherProductsTotalOtherProductSalesMember2021-01-012021-06-300000882095us-gaap:ProductMembercountry:US2022-01-012022-06-300000882095srt:EuropeMemberus-gaap:ProductMember2022-01-012022-06-300000882095us-gaap:ProductMembergild:OtherInternationalMember2022-01-012022-06-300000882095us-gaap:ProductMembercountry:US2021-01-012021-06-300000882095srt:EuropeMemberus-gaap:ProductMember2021-01-012021-06-300000882095us-gaap:ProductMembergild:OtherInternationalMember2021-01-012021-06-300000882095country:USgild:RoyaltyContractAndOtherMember2022-01-012022-06-300000882095srt:EuropeMembergild:RoyaltyContractAndOtherMember2022-01-012022-06-300000882095gild:RoyaltyContractAndOtherMembergild:OtherInternationalMember2022-01-012022-06-300000882095country:USgild:RoyaltyContractAndOtherMember2021-01-012021-06-300000882095srt:EuropeMembergild:RoyaltyContractAndOtherMember2021-01-012021-06-300000882095gild:RoyaltyContractAndOtherMembergild:OtherInternationalMember2021-01-012021-06-300000882095country:US2022-01-012022-06-300000882095srt:EuropeMember2022-01-012022-06-300000882095gild:OtherInternationalMember2022-01-012022-06-300000882095country:US2021-01-012021-06-300000882095srt:EuropeMember2021-01-012021-06-300000882095gild:OtherInternationalMember2021-01-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMembergild:AmerisourcebergenCorpMemberus-gaap:CustomerConcentrationRiskMember2022-04-012022-06-30xbrli:pure0000882095us-gaap:RevenueFromContractWithCustomerMembergild:AmerisourcebergenCorpMemberus-gaap:CustomerConcentrationRiskMember2021-04-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMembergild:AmerisourcebergenCorpMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-06-300000882095us-gaap:RevenueFromContractWithCustomerMembergild:AmerisourcebergenCorpMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:CardinalHealthIncMember2022-04-012022-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:CardinalHealthIncMember2021-04-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:CardinalHealthIncMember2022-01-012022-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:CardinalHealthIncMember2021-01-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:MckessonCorpMember2022-04-012022-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:MckessonCorpMember2021-04-012021-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:MckessonCorpMember2022-01-012022-06-300000882095us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMembergild:MckessonCorpMember2021-01-012021-06-300000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:USTreasurySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:ForeignGovernmentDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CertificatesOfDepositMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CertificatesOfDepositMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CertificatesOfDepositMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CertificatesOfDepositMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CertificatesOfDepositMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel1Membergild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Membergild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Membergild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Membergild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MoneyMarketFundsMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MoneyMarketFundsMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MoneyMarketFundsMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMembergild:GalapagosMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMembergild:GalapagosMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMembergild:GalapagosMember2021-12-310000882095us-gaap:FairValueInputsLevel1Membergild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel2Membergild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000882095gild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-06-300000882095gild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel1Membergild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel2Membergild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000882095gild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-12-310000882095gild:ArcusBiosciencesIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:EquitySecuritiesMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembergild:DeferredCompensationPlanMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMembergild:DeferredCompensationPlanMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembergild:DeferredCompensationPlanMember2021-12-310000882095us-gaap:FairValueInputsLevel1Membergild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Membergild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095gild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095gild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Membergild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Membergild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095gild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095gild:ForeignCurrencyDerivativeContractsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel1Membergild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095us-gaap:FairValueInputsLevel2Membergild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300000882095gild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095gild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel1Membergild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095us-gaap:FairValueInputsLevel2Membergild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000882095gild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095gild:MYRGmbHMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000882095us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300000882095us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2022-03-310000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2021-03-310000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2021-12-310000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2020-12-310000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2022-04-012022-06-300000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2021-04-012021-06-300000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2022-01-012022-06-300000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2021-01-012021-06-300000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2022-06-300000882095gild:MYRGmbHMembergild:ContingentConsiderationLiabilityMember2021-06-300000882095us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembergild:ImmunomedicsIncMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:EstimateOfFairValueFairValueDisclosureMembergild:ImmunomedicsIncMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:FairValueMeasurementsNonrecurringMembergild:ImmunomedicsIncMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310000882095us-gaap:FairValueMeasurementsNonrecurringMembergild:ImmunomedicsIncMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-06-300000882095us-gaap:FairValueMeasurementsNonrecurringMembergild:InProcessResearchAndDevelopmentTrodelvyForHRHER2Member2022-01-012022-06-300000882095us-gaap:USTreasurySecuritiesMember2022-06-300000882095us-gaap:USTreasurySecuritiesMember2021-12-310000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-06-300000882095us-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-12-310000882095us-gaap:ForeignGovernmentDebtSecuritiesMember2022-06-300000882095us-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000882095us-gaap:CertificatesOfDepositMember2022-06-300000882095us-gaap:CertificatesOfDepositMember2021-12-310000882095us-gaap:CorporateDebtSecuritiesMember2022-06-300000882095us-gaap:CorporateDebtSecuritiesMember2021-12-310000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMember2022-06-300000882095gild:ResidentialMortgageAndAssetBackedSecuritiesMember2021-12-310000882095us-gaap:CashAndCashEquivalentsMember2022-06-300000882095us-gaap:CashAndCashEquivalentsMember2021-12-310000882095gild:MarketableSecuritiesCurrentMember2022-06-300000882095gild:MarketableSecuritiesCurrentMember2021-12-310000882095gild:MarketableSecuritiesNoncurrentMember2022-06-300000882095gild:MarketableSecuritiesNoncurrentMember2021-12-310000882095us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-06-300000882095us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000882095us-gaap:OtherNoncurrentAssetsMember2022-06-300000882095us-gaap:OtherNoncurrentAssetsMember2021-12-310000882095us-gaap:EquitySecuritiesMember2022-06-300000882095us-gaap:EquitySecuritiesMember2021-12-310000882095gild:EquitySecuritiesDonationMembergild:GileadFoundationMember2022-04-012022-06-300000882095gild:EquitySecuritiesDonationMembergild:GileadFoundationMember2021-04-012021-06-300000882095srt:MaximumMember2022-01-012022-06-300000882095us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-06-300000882095us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2022-06-300000882095us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-06-300000882095us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-06-300000882095us-gaap:DesignatedAsHedgingInstrumentMember2022-06-300000882095us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-06-300000882095us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2022-06-300000882095us-gaap:NondesignatedMember2022-06-300000882095us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000882095us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2021-12-310000882095us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000882095us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000882095us-gaap:DesignatedAsHedgingInstrumentMember2021-12-310000882095us-gaap:NondesignatedMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310000882095us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2021-12-310000882095us-gaap:NondesignatedMember2021-12-310000882095gild:MYRGmbHMember2021-03-042021-03-04iso4217:EUR0000882095gild:MYRGmbHMembersrt:MaximumMember2021-03-040000882095gild:MYRGmbHMember2021-03-040000882095gild:MYRGmbHMember2022-06-300000882095gild:MYRGmbHMember2022-01-012022-03-310000882095gild:DragonflyTherapeuticsCollaborationAgreementMembergild:DragonflyTherapeuticsIncMember2022-04-012022-04-300000882095gild:DragonflyTherapeuticsCollaborationAgreementMembergild:DragonflyTherapeuticsIncMember2022-06-300000882095gild:ArcusBiosciencesIncMembergild:ArcusCollaborationAgreementAndStockPurchaseAgreementsMember2020-05-272020-05-270000882095gild:ArcusBiosciencesIncMembergild:ArcusCollaborationAgreementAndStockPurchaseAgreementsMember2021-11-18gild:program0000882095gild:ArcusBiosciencesIncMembergild:ArcusCollaborationAgreementAndStockPurchaseAgreementsMember2021-12-212021-12-210000882095gild:ArcusCollaborationAgreementMembergild:ArcusBiosciencesIncMember2021-12-310000882095gild:ArcusBiosciencesIncMembergild:ArcusCollaborationAgreementAndStockPurchaseAgreementsMember2022-01-012022-01-310000882095gild:MYRGmbHMember2022-01-012022-06-300000882095gild:IntangibleAssetSofosbuvirMember2022-06-300000882095gild:IntangibleAssetSofosbuvirMember2021-12-310000882095gild:AxicabtageneciloleucelDLBCLMember2022-06-300000882095gild:AxicabtageneciloleucelDLBCLMember2021-12-310000882095gild:TrodelvyMember2022-06-300000882095gild:TrodelvyMember2021-12-310000882095gild:HepcludexMember2022-06-300000882095gild:HepcludexMember2021-12-310000882095us-gaap:OtherIntangibleAssetsMember2022-06-300000882095us-gaap:OtherIntangibleAssetsMember2021-12-310000882095us-gaap:InProcessResearchAndDevelopmentMember2022-06-300000882095us-gaap:InProcessResearchAndDevelopmentMember2021-12-310000882095gild:ImmunomedicsIncMembergild:InProcessResearchAndDevelopmentTrodelvyForHRHER2Member2020-12-310000882095gild:InProcessResearchAndDevelopmentTrodelvyForHRHER2Member2022-03-310000882095gild:ImmunomedicsIncMembergild:InProcessResearchAndDevelopmentTrodelvyForHRHER2Memberus-gaap:MeasurementInputDiscountRateMember2022-03-310000882095us-gaap:FairValueMeasurementsNonrecurringMembergild:InProcessResearchAndDevelopmentTrodelvyForHRHER2Member2022-01-012022-03-310000882095us-gaap:SeniorNotesMembergild:A195SeniorUnsecuredNotesDueMarch2022Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A195SeniorUnsecuredNotesDueMarch2022Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A325SeniorUnsecuredNotesDueSeptember2022Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A325SeniorUnsecuredNotesDueSeptember2022Member2021-12-310000882095gild:A250SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A250SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:A075SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A075SeniorUnsecuredNotesDueSeptember2023Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:A370SeniorUnsecuredNotesDueApril2024Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A370SeniorUnsecuredNotesDueApril2024Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:A350SeniorUnsecuredNotesDueFebruary2025Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A350SeniorUnsecuredNotesDueFebruary2025Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:A365SeniorUnsecuredNotesDueMarch2026Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A365SeniorUnsecuredNotesDueMarch2026Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:A295SeniorUnsecuredNotesDueMarch2027Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A295SeniorUnsecuredNotesDueMarch2027Memberus-gaap:SeniorNotesMember2021-12-310000882095us-gaap:SeniorNotesMembergild:A120SeniorUnsecuredNotesDueOctober2027Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A120SeniorUnsecuredNotesDueOctober2027Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A165SeniorUnsecuredNotesDueOctober2030Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A165SeniorUnsecuredNotesDueOctober2030Member2021-12-310000882095gild:A460SeniorUnsecuredNotesDueSeptember2035Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A460SeniorUnsecuredNotesDueSeptember2035Memberus-gaap:SeniorNotesMember2021-12-310000882095us-gaap:SeniorNotesMembergild:A400SeniorUnsecuredNotesDueSeptember2036Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A400SeniorUnsecuredNotesDueSeptember2036Member2021-12-310000882095gild:A260SeniorUnsecuredNotesDueOctober2040Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A260SeniorUnsecuredNotesDueOctober2040Memberus-gaap:SeniorNotesMember2021-12-310000882095us-gaap:SeniorNotesMembergild:A565SeniorUnsecuredNotesDueDecember2041Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A565SeniorUnsecuredNotesDueDecember2041Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A480SeniorUnsecuredNotesDueApril2044Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A480SeniorUnsecuredNotesDueApril2044Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A450SeniorUnsecuredNotesDueFebruary2045Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A450SeniorUnsecuredNotesDueFebruary2045Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A475SeniorUnsecuredNotesDueMarch2046Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A475SeniorUnsecuredNotesDueMarch2046Member2021-12-310000882095us-gaap:SeniorNotesMembergild:A415SeniorUnsecuredNotesDueMarch2047Member2022-06-300000882095us-gaap:SeniorNotesMembergild:A415SeniorUnsecuredNotesDueMarch2047Member2021-12-310000882095gild:A280SeniorUnsecuredNotesDueOctober2050Memberus-gaap:SeniorNotesMember2022-06-300000882095gild:A280SeniorUnsecuredNotesDueOctober2050Memberus-gaap:SeniorNotesMember2021-12-310000882095gild:SeniorNotesAndMediumTermNotesMember2022-06-300000882095gild:SeniorNotesAndMediumTermNotesMember2021-12-310000882095us-gaap:NotesPayableOtherPayablesMember2022-06-300000882095us-gaap:NotesPayableOtherPayablesMember2021-12-310000882095us-gaap:SeniorNotesMembergild:A195SeniorUnsecuredNotesDueMarch2022Member2022-02-012022-02-280000882095us-gaap:SeniorNotesMemberus-gaap:SubsequentEventMembergild:A325SeniorUnsecuredNotesDueSeptember2022Member2022-07-012022-07-010000882095us-gaap:RevolvingCreditFacilityMembergild:CreditFacilityDueJune2025Memberus-gaap:LineOfCreditMember2022-06-300000882095us-gaap:RevolvingCreditFacilityMembergild:CreditFacilityDueJune2025Memberus-gaap:LineOfCreditMember2021-12-3100008820952022-02-012022-02-280000882095gild:JunoTherapeuticsIncAndSloanKetteringCancerCenterMember2019-12-012019-12-310000882095gild:JunoTherapeuticsIncAndSloanKetteringCancerCenterMember2020-04-300000882095gild:PreExposureProphylaxisMember2020-04-30gild:agreement00008820952019-12-012019-12-31gild:patentgild:defendant00008820952021-10-012021-10-3100008820952022-03-012022-03-310000882095gild:EuropeanPatentClaims2024ExpirationMember2019-12-31gild:opposingParty0000882095gild:EuropeanPatentClaims2032ExpirationMember2019-12-310000882095gild:EuropeanPatentClaims2028ExpirationMember2016-01-012016-12-31gild:party0000882095gild:EuropeanPatentClaims2028ExpirationMember2019-12-310000882095gild:ProductLiabilityMember2022-01-012022-06-30gild:lawsuitgild:plaintiff0000882095gild:A2016StockRepurchaseProgramMember2016-03-310000882095gild:A2020StockRepurchaseProgramMember2020-03-310000882095us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-12-310000882095us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-06-300000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-06-300000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-012022-06-300000882095us-gaap:AccumulatedTranslationAdjustmentMember2022-06-300000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-06-300000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-06-300000882095us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-12-310000882095us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-06-300000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-012021-06-300000882095us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000882095us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300000882095us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-06-300000882095gild:MiroBioLtdMembersrt:ScenarioForecastMemberus-gaap:SubsequentEventMember2022-08-012022-08-31

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________

Commission File No. 0-19731
 
GILEAD SCIENCES, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware94-3047598
(State or Other Jurisdiction of Incorporation or Organization)(IRS Employer Identification No.)
333 Lakeside Drive, Foster City, California 94404
(Address of principal executive offices) (Zip Code)
650-574-3000
(Registrant’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value, $0.001 per shareGILDThe Nasdaq Global Select Market
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x    No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer x Accelerated filer ¨ Non-accelerated filer ¨    
Smaller reporting company Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes     No x
Number of shares outstanding of the issuer’s common stock, par value $0.001 per share, as of July 29, 2022: 1,253,367,394



GILEAD SCIENCES, INC.
INDEX
We own or have rights to various trademarks and trade names used in our business, including the following: GILEAD®, GILEAD SCIENCES®, AMBISOME®, ATRIPLA®, BIKTARVY®, CAYSTON®, COMPLERA®, DESCOVY®, DESCOVY FOR PREP®, EMTRIVA®, EPCLUSA®, EVIPLERA®, GENVOYA®, HARVONI®, HEPCLUDEX® (BULEVIRTIDE), HEPSERA®, JYSELECA® (FILGOTINIB), LETAIRIS®, ODEFSEY®, RANEXA®, SOVALDI®, STRIBILD®, TECARTUS®, TRODELVY®, TRUVADA®, TRUVADA FOR PREP®, TYBOST®, VEKLURY®, VEMLIDY®, VIREAD®, VOSEVI®, YESCARTA® and ZYDELIG®. This report also refers to trademarks, service marks and trade names of other companies.



This Quarterly Report on Form 10-Q, including Part I, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors, contains forward-looking statements regarding future events and our future results that are subject to the safe harbors created under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended. Words such as “expect,” “anticipate,” “target,” “goal,” “project,” “hope,” “intend,” “plan,” “believe,” “seek,” “estimate,” “continue,” “may,” “could,” “should,” “might,” “forecast” and variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, any statements other than statements of historical fact are forward-looking statements, including statements regarding overall trends; operating cost and revenue trends; liquidity and capital needs; plans and expectations with respect to products, product candidates, corporate strategy, business and operations, financial projections and the use of capital; collaboration and licensing arrangements; ongoing litigation and investigation matters; statements regarding the anticipated future impact on our business of the ongoing coronavirus disease 2019 (“COVID-19”) and related public health measures; and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends and similar expressions.
We have based these forward-looking statements on our current expectations about future events. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Our actual results may differ materially from those suggested by these forward-looking statements for various reasons, including those identified in Part II, Item 1A. Risk Factors. Given these risks and uncertainties, you are cautioned not to place undue reliance on forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof unless otherwise specified. Except as required under federal securities laws and the rules and regulations of the U.S. Securities and Exchange Commission, we do not undertake, and specifically decline, any obligation to update any of these statements or to publicly announce the results of any revisions to any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions or otherwise. In evaluating our business, you should carefully consider the risks described in Part II, Item 1A. Risk Factors of this Quarterly Report in addition to the other information in this Quarterly Report on Form 10-Q. Any of the risks contained herein could materially and adversely affect our business, results of operations and financial condition.

2


PART I.    FINANCIAL INFORMATION
Item 1.    CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
GILEAD SCIENCES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)
(in millions, except per share amounts)June 30, 2022December 31, 2021
Assets  
Current assets:  
Cash and cash equivalents$4,739 $5,338 
Short-term marketable debt securities924 1,182 
Accounts receivable, net4,118 4,493 
Inventories1,494 1,618 
Prepaid and other current assets1,900 2,141 
Total current assets13,175 14,772 
Property, plant and equipment, net5,299 5,121 
Long-term marketable debt securities1,337 1,309 
Intangible assets, net29,885 33,455 
Goodwill8,314 8,332 
Other long-term assets4,860 4,963 
Total assets$62,870 $67,952 
Liabilities and Stockholders’ Equity  
Current liabilities:  
Accounts payable$565 $705 
Accrued government and other rebates3,519 3,244 
Accrued and other current liabilities4,115 6,145 
Current portion of long-term debt and other obligations, net1,021 1,516 
Total current liabilities9,220 11,610 
Long-term debt, net25,195 25,179 
Long-term income taxes payable3,888 4,767 
Deferred tax liability3,364 4,356 
Other long-term obligations988 976 
Commitments and contingencies (Note 10)
Stockholders’ equity:  
Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding
  
Common stock, par value $0.001 per share; 5,600 shares authorized; 1,254 shares issued and outstanding
1 1 
Additional paid-in capital5,031 4,661 
Accumulated other comprehensive income87 83 
Retained earnings15,117 16,324 
Total Gilead stockholders’ equity20,236 21,069 
Noncontrolling interest(21)(5)
Total stockholders’ equity20,215 21,064 
Total liabilities and stockholders’ equity$62,870 $67,952 


See accompanying notes.
2


GILEAD SCIENCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited)
 Three Months EndedSix Months Ended
June 30,June 30,
(in millions, except per share amounts)2022202120222021
Revenues:
Product sales$6,138 $6,152 $12,672 $12,492 
Royalty, contract and other revenues122 65 178 148 
Total revenues6,260 6,217 12,850 12,640 
Costs and expenses:
Cost of goods sold1,442 1,390 2,866 2,751 
Research and development expenses1,102 1,092 2,280 2,142 
Acquired in-process research and development expenses330 138 338 205 
In-process research and development impairment  2,700  
Selling, general and administrative expenses1,357 1,351 2,440 2,406 
Total costs and expenses4,231 3,971 10,624 7,504 
Income from operations2,029 2,246 2,226 5,136 
Interest expense(242)(256)(480)(513)
Other income (expense), net(284)(173)(395)(542)
Income before income taxes1,503 1,817 1,351 4,081 
Income tax expense(368)(300)(204)(842)
Net income1,135 1,517 1,147 3,239 
Net loss attributable to noncontrolling interest9 5 16 12 
Net income attributable to Gilead$1,144 $1,522 $1,163 $3,251 
Net income per share attributable to Gilead common stockholders – basic
$0.91 $1.21 $0.93 $2.59 
Shares used in per share calculation – basic
1,256 1,255 1,255 1,256 
Net income per share attributable to Gilead common stockholders – diluted
$0.91 $1.21 $0.92 $2.58 
Shares used in per share calculation – diluted
1,260 1,260 1,261 1,261 





















See accompanying notes.

3


GILEAD SCIENCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(unaudited)
Three Months EndedSix Months Ended
June 30,June 30,
(in millions)2022202120222021
Net income$1,135 $1,517 $1,147 $3,239 
Other comprehensive income:
Net foreign currency translation gain (loss), net of tax(26)(5)(21)5 
Available-for-sale debt securities:
Net unrealized loss, net of tax(12)(1)(31)(3)
Reclassifications to net income, net of tax1  1  
Net change(11)(1)(30)(3)
Cash flow hedges:
Net unrealized gain (loss), net of tax 90 (13)114 55 
Reclassifications to net income, net of tax(39)20 (59)42 
Net change51 7 55 97 
Other comprehensive income14 1 4 99 
Comprehensive income1,149 1,518 1,151 3,338 
Comprehensive loss attributable to noncontrolling interest9 5 16 12 
Comprehensive income attributable to Gilead$1,158 $1,523 $1,167 $3,350 































See accompanying notes.
4


GILEAD SCIENCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(unaudited)
Three Months Ended June 30, 2022
(in millions, except per share amounts)Gilead Stockholders’ Equity Noncontrolling
Interest
Total
Stockholders’
Equity
Common Stock 
Additional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Retained
Earnings
SharesAmount
Balance as of March 31, 20221,255 $1 $4,867 $73 $14,986 $(12)$19,915 
Net income (loss)— — — — 1,144 (9)1,135 
Other comprehensive income, net of tax— — — 14 — — 14 
Issuances under equity incentive plans— — 3 — — — 3 
Stock-based compensation— — 164 — — — 164 
Repurchases of common stock(1)— (3)— (81)— (84)
Dividends declared ($0.73 per share)
— — — — (932)— (932)
Balance as of June 30, 20221,254 $1 $5,031 $87 $15,117 $(21)$20,215 

Six Months Ended June 30, 2022
(in millions, except per share amounts)Gilead Stockholders’ Equity Noncontrolling
Interest
Total
Stockholders’
Equity
Common Stock 
Additional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Retained
Earnings
SharesAmount
Balance as of December 31, 20211,254 $1 $4,661 $83 $16,324 $(5)$21,064 
Net income (loss)— — — — 1,163 (16)1,147 
Other comprehensive income, net of tax— — — 4 — — 4 
Issuances under employee stock purchase plan1 — 73 — — — 73 
Issuances under equity incentive plans7 — 24 — — — 24 
Stock-based compensation— — 295 — — — 295 
Repurchases of common stock(8)— (22)— (506)— (528)
Dividends declared ($1.46 per share)
— — — — (1,864)— (1,864)
Balance as of June 30, 20221,254 $1 $5,031 $87 $15,117 $(21)$20,215 

















See accompanying notes.
5


Three Months Ended June 30, 2021
(in millions, except per share amounts)Gilead Stockholders’ Equity Noncontrolling
Interest
Total
Stockholders’
Equity
Common Stock 
Additional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Retained
Earnings
SharesAmount
Balance as of March 31, 20211,254 $1 $4,092 $38 $14,821 $12 $18,964 
Net income (loss)— — — — 1,522 (5)1,517 
Other comprehensive income, net of tax— — — 1 — — 1 
Issuances under equity incentive plans1 — 12 — — — 12 
Stock-based compensation— — 168 — — — 168 
Repurchases of common stock(1)— (1)— (48)— (49)
Dividends declared ($0.71 per share)
— — — — (903)— (903)
Balance as of June 30, 20211,254 $1 $4,271 $39 $15,392 $7 $19,710 

Six Months Ended June 30, 2021
(in millions, except per share amounts)Gilead Stockholders’ Equity Noncontrolling
Interest
Total
Stockholders’
Equity
Common Stock 
Additional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Retained
Earnings
SharesAmount
Balance as of December 31, 20201,254 $1 $3,880 $(60)$14,381 $19 $18,221 
Net income (loss)— — — — 3,251 (12)3,239 
Other comprehensive income, net of tax— — — 99 — — 99 
Issuances under employee stock purchase plan1 — 76 — — — 76 
Issuances under equity incentive plans6 — 24 — — — 24 
Stock-based compensation— — 308 — — — 308 
Repurchases of common stock(7)— (17)— (431)— (448)
Dividends declared ($1.42 per share)
— — — — (1,809)— (1,809)
Balance as of June 31, 20211,254 $1 $4,271 $39 $15,392 $7 $19,710 





















See accompanying notes.
6


GILEAD SCIENCES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
Six Months Ended
June 30,
(in millions)20222021
Operating Activities:
Net income$1,147 $3,239 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation expense160 157 
Amortization expense890